Gofore reported continued good sales momentum in March and the Q1 organic sales growth improved to 2%, in line with our assumption. However, the acquisition synergies are not yet fully visible and the company continued investments in growth. Thus the quarter saw EBITA coming somewhat behind our estimate. Despite this, we remain confident that the profitability outlook remains benign.
LÄS MER
